J. Rapp Edward's Insider Trades & SAST Disclosures
J. Rapp Edward's most recent trade in Xos Inc was a trade of 1,475 Common Stock done . Disclosure was reported to the exchange on Jan. 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern J. Rapp Edward.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Xos Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 1,475 | 56,509 | - | 0 | Common Stock | |
| Xos Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 1,065 | 56,099 | - | 0 | Common Stock | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 182 | 26,976 | - | - | Stock Equivalent Units | |
| Xos Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2024 | 1,065 | 55,034 | - | 0 | Common Stock | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 164 | 26,544 | - | - | Stock Equivalent Units | |
| Xos Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2024 | 28,694 | 53,252 | - | 0 | Common Stock | |
| Xos Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2024 | 717 | 53,969 | - | 0 | Common Stock | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 225 | 26,170 | - | - | Stock Equivalent Units | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 1,322 | 31,356 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Xos Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2024 | 445 | 24,558 | - | 0 | Common Stock | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 212 | 25,701 | - | - | Stock Equivalent Units | |
| Xos Inc | J. Rapp Edward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2024 | 650 | 24,113 | - | 0 | Common Stock | |
| Abbvie Inc | Edward Rapp J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 250 | 25,266 | - | - | Stock Equivalent Units | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 259 | 24,750 | - | - | Stock Equivalent Units | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 287 | 24,254 | - | - | Stock Equivalent Units | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 1,450 | 30,034 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 243 | 23,727 | - | - | Stock Equivalent Units | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 239 | 23,256 | - | - | Stock Equivalent Units | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 288 | 22,806 | - | - | Stock Equivalent Units | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 237 | 22,296 | - | - | Stock Equivalent Units | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 1,421 | 28,584 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 217 | 21,860 | - | - | Stock Equivalent Units | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 326 | 20,941 | - | - | Stock Equivalent Units | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 312 | 20,390 | - | - | Stock Equivalent Units | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 1,681 | 27,163 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 325 | 19,855 | - | - | Stock Equivalent Units | |
| Abbvie Inc | Edward J. Rapp | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Sep 2020 | 7,513 | 25,482 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Abbvie Inc | Edward J. Rapp | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 30 Sep 2020 | 7,513 | 10,388 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 402 | 18,735 | - | - | Stock Equivalent Units | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 350 | 18,108 | - | - | Stock Equivalent Units | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2020 | 2,333 | 32,995 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Abbvie Inc | Edward J. Rapp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2020 | 446 | 17,530 | - | - | Stock Equivalent Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges